The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.
about
Self management programme for ankylosing spondylitisClassification criteria for spondyloarthropathiesNon-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences?Are patient-reported outcome instruments for ankylosing spondylitis fit for purpose for the axial spondyloarthritis patient? A qualitative and psychometric analysisA registry of ankylosing spondylitis registries and prospects for global interfacingShould axial spondyloarthritis without radiographic changes be treated with anti-TNF agents?Evaluation of the validity of the different arms of the ASAS set of criteria for axial spondyloarthritis and description of the different imaging abnormalities suggestive of spondyloarthritis: data from the DESIR cohort.Results from Polish Spondyloarthritis Initiative registry (PolSPI) - methodology and data from - the first year of observationEffectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis.The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United StatesIdentification of RGS1 as a candidate biomarker for undifferentiated spondylarthritis by genome-wide expression profiling and real-time polymerase chain reaction.Advances in managing ankylosing spondylitisEarly axial spondyloarthritis.Spondyloarthritides: evolving therapiesEvaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study.Spontaneous, drug-induced, and drug-free remission in peripheral and axial spondyloarthritis.Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trialIdentifying patients with axial spondyloarthritis in primary care: how useful are items indicative of inflammatory back pain?Spinal radiographic progression in patients with ankylosing spondylitis treated with TNF-α blocking therapy: a prospective longitudinal observational cohort study.Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trialDiscriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic aEpidemiology of spondyloarthritis.Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis.The British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatment.Osteoimmunology and osteoporosis.Predictive Factors of Clinical Response of Infliximab Therapy in Active Nonradiographic Axial Spondyloarthritis PatientsBack pain and health status in patients with clinically diagnosed ankylosing spondylitis, psoriatic arthritis and other spondyloarthritis: a cross-sectional population-based study.Acute anterior uveitis and other extra-articular manifestations of spondyloarthritis.Web-based physiotherapy for people with axial spondyloarthritis (WEBPASS) - a study protocol.The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: A critical appraisal for the pediatric rheumatologist.Insulin-Like Growth Factor I Does Not Drive New Bone Formation in Experimental Arthritis.Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis.Trends in treatment and outcomes of ankylosing spondylitis in outpatient rheumatological care in Germany between 2000 and 2012.Advances in the treatment of inflammatory arthritis.ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis.Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case-control study based on national registers.Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey.Costs of early spondyloarthritis: estimates from the first 3 years of the DESIR cohortEfficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).
P2860
Q24187492-F20B0FA1-527D-470B-8407-FD0CF3977EE4Q24617746-9D5B6079-325B-4EFD-AB40-7BAFE3081CE4Q26777908-B0F389CB-B2D3-4201-953E-1BF99C24222AQ26823664-A2C23406-5CF5-4383-84B5-FFBC8649CA13Q27026669-817DCF75-B295-49C1-BD38-EC9F6063A5ACQ30239856-7F2B5E5D-EE2A-48A6-A963-133919F29319Q30725992-546B92B2-BEE8-4D4D-88DE-9E485B1A8778Q33720765-9CC17B6C-F445-4BC5-BB54-FE6736B4E971Q33923298-3B30E245-05D3-4078-8CAD-9DDDC98E66C2Q34004546-4BC51905-E1BB-4CD9-952F-18B4BB452EEBQ34117039-936679F1-556A-45BC-BE9E-53AA93B6389FQ34201927-B561553B-A7E9-434F-A83C-E4A3317B5898Q34505203-6E2987D9-EC86-47AD-9C30-46E4E330AD81Q34613907-907731A8-2E0A-46D3-9F79-DBE4AD69A9D4Q34808170-0AEA5C01-8A45-4B2D-B873-D471902B99C9Q34894874-89096C7D-4A46-40CB-91C5-A08DCAF55A25Q35194568-866FFA61-4147-4EAA-85EE-587BA8D4A938Q35208425-9508D64D-E8D5-4FD0-B7DF-9F48DD44B87BQ35449032-36D9E99F-F4E8-479D-9D32-88E5F6D2CC9CQ35537104-7F14A825-141B-4E19-A0F5-F43D2E5D61E9Q35664666-B50D5150-BF9E-426D-B9C8-8F527B5451B4Q35750729-782C7542-1A24-4034-AF40-AF3A5D43A481Q35809286-5CA92B29-D8E5-4E68-A79A-2BBD8ADFF8BDQ35838797-3BBAE349-137C-40CD-9505-2D5CB88B83E9Q35840701-5BF714F9-F78E-439F-B9F6-0DA279F136BDQ35931041-6EC7B460-201D-40C9-8174-55BF2AC66FC1Q35938403-DAC7A35A-78EB-40E3-A260-31CC290DCD6AQ36017682-8C7A2945-145B-4A2F-8376-1FF2E251D384Q36110768-0274F24F-2053-4C7D-87C4-A19612F18FC0Q36112605-9C18DEE8-2DC8-4C28-9836-0D04F7BB8EF5Q36151103-C36F2A3B-44FD-48DF-8A71-17EFFD1A4393Q36151781-F7B868B2-9056-43E0-83FC-4BAD9231441AQ36182303-7DF7DA5C-9B38-4C00-B8AD-3277853E1065Q36288599-FC3BC0B9-6889-4A37-B403-6C9DB8E21D4EQ36366162-7F942795-F150-442B-9A66-0C7C77F26A36Q36477447-58D51789-DAEB-4F45-8935-29DC69C004BFQ36477492-9213B184-FEDC-4EA7-8462-0F6261FE3DCEQ36758296-5C9FB694-C6C9-43FA-A458-09BB75EDD196Q36773679-B3049DCB-D6A9-47E1-9D6F-808FA11D0CDFQ36876679-448D29A8-3697-4E10-AFC3-E0761B48F8E2
P2860
The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The early disease stage in axi ...... yloarthritis Inception Cohort.
@en
The early disease stage in axi ...... yloarthritis Inception Cohort.
@nl
type
label
The early disease stage in axi ...... yloarthritis Inception Cohort.
@en
The early disease stage in axi ...... yloarthritis Inception Cohort.
@nl
prefLabel
The early disease stage in axi ...... yloarthritis Inception Cohort.
@en
The early disease stage in axi ...... yloarthritis Inception Cohort.
@nl
P2093
P2860
P356
P1476
The early disease stage in axi ...... yloarthritis Inception Cohort.
@en
P2093
Elisabeth Märker-Hermann
Henning Zeidler
Hildrun Haibel
Joachim Listing
Joachim Sieper
Jürgen Braun
Martin Rudwaleit
Xenofon Baraliakos
P2860
P304
P356
10.1002/ART.24483
P577
2009-03-01T00:00:00Z